Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?

Lancet Neurology

Volumn 6, Issue 7, 2007, Pages 578-579

  Lim, Hoong Sern ^a   Lip, Gregory YH ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; HEPARINIZATION; HUMAN; LETTER; LUNG EMBOLISM; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; THROMBOSIS;

EID: 34250362192     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70159-X     Document Type: Letter

References (10)

1. Kelly J., Rudd A., Lewis R., and Hunt B. Venous thromboembolism after acute stroke. Stroke 32 (2001) 262-267
2. Mazzone C., Chiodo Grandi F., Sandercock P., Miccio M., and Salvi R. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 4 (2004) CD001922
3. Sherman D., Albers G., Bladin C., et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL study): an open-label randomised comparison. Lancet 369 (2007) 1347-1355
4. Sandercock P., van den Belt A., Lindley R., et al. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 56 (1993) 17-25
5. Leyvraz P., Richard J., and Bachmann F. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 309 (1983) 954-958
6. Weitz J. Low-molecular-weight heparins. N Engl J Med 337 (1997) 688-698
7. Mismetti P., Laporte-Simitsidis S., Tardy B., et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 83 (2000) 14-19
8. Turpie A., Levine M., Hirsh J., et al. Double-blind randomised trial of ORG 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1 (1987) 523-526
9. Gubitz G., Sandercock P., and Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 3 (2004) CD000024
10. Kearon C. Natural history of venous thromboembolism. Circulation 107 (2003) 22-30